MDT241115C74000
- 0.00
- 0.000.00%
Medtronic Newsroom
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know
Catalyst Watch: Nvidia Earnings, Microsoft Ignite, Crypto Confidence, and P&G Event
Medtech Shouldn't Be Greatly Impacted by RFK Jr. at HHS, Wells Fargo Says
Least Shorted S&P 500 Stocks in October
TD Cowen Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $95
Medtronic's Growth Potential and Favorable Market Conditions Reinforce Buy Rating
Mairs and Power's Strategic Adjustments in Q3 2024: A Closer Look at Medtronic PLC
BofA Securities Maintains Medtronic(MDT.US) With Buy Rating
Bank of America Securities Keeps Their Buy Rating on Medtronic (MDT)
Insights Into Medtronic (MDT) Q2: Wall Street Projections for Key Metrics
Barclays Maintains Medtronic(MDT.US) With Buy Rating, Maintains Target Price $105
Analysts Have Conflicting Sentiments on These Healthcare Companies: PTC Therapeutics (PTCT), Medtronic (MDT) and OptimizeRx (OPRX)
Barclays Remains a Buy on Medtronic (MDT)
Express News | Medtronic PLC : JP Morgan Raises Target Price to $95 From $88
Earnings Preview: Medtronic to Report Financial Results Pre-market on November 19
$Medtronic(MDT.US)$ is scheduled to release its financial results pre-market on November 19 ET. Earnings PreviewAnalysts estimate $Medtronic(MDT.US)$ to post revenue of USD8.27B for 2025Q2, up 3.64%
Sector Update: Health Care
Medtronic Sued by Hexagon Health for Alleged Patent Infringement
Orchestra BioMed Reports Third Quarter 2024 Financial Results and Provides a Business Update
CINNO Research: The domestic XR market sales volume in Q3 24 was 0.108 million units, a 35% decrease compared to the previous quarter.
In the segmented market, the performance of consumer-grade VR devices is particularly worrying, with sales of 0.046 million units, a severe decrease compared to the previous period. This grim situation is mainly attributed to the lack of high-quality VR content and applications, as well as the high development costs, which have long plagued developers.
With Medtronic Plc (NYSE:MDT) It Looks Like You'll Get What You Pay For